Symbols / PHGE $1.43 -2.05% BiomX Inc.

Healthcare • Biotechnology • United States • ASE
PHGE Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company's phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware.

Fundamentals
Scroll to Statements
Market Cap 12.54M Enterprise Value 17.97M Income -36.20M Sales — Book/sh -12.50 Cash/sh 2.74
Dividend Yield — Payout 0.00% Employees 20 IPO — P/E — Forward P/E -0.11
PEG — P/S — P/B -0.11 P/C — EV/EBITDA -0.64 EV/Sales —
Quick Ratio 0.70 Current Ratio 0.87 Debt/Eq — LT Debt/Eq — EPS (ttm) -37.05 EPS next Y -12.98
EPS Growth — Revenue Growth — Earnings 2026-05-14 ROA -78.85% ROE -3.17% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 8.77M Shs Float 1.12M Short Float 1.31%
Short Ratio 1.04 Short Interest — 52W High 14.71 52W Low 1.40 Beta 1.70 Avg Volume 1.06M
Volume 80.79K Target Price $304.00 Recom None Prev Close $1.46 Price $1.43 Change -2.05%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$304.00
Mean price target
2. Current target
$1.43
Latest analyst target
3. DCF / Fair value
$-28.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.43
Low
$304.00
High
$304.00
Mean
$304.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-09 down HC Wainwright & Co. Buy → Neutral —
2025-11-26 reit HC Wainwright & Co. Buy → Buy $26
2025-11-25 main HC Wainwright & Co. Buy → Buy $26
2025-08-20 reit HC Wainwright & Co. Buy → Buy $15
2025-05-16 main HC Wainwright & Co. Buy → Buy $15
2025-04-04 reit HC Wainwright & Co. Buy → Buy $21
2025-04-01 main HC Wainwright & Co. Buy → Buy $21
2025-01-10 reit HC Wainwright & Co. Buy → Buy $2
2025-01-08 main HC Wainwright & Co. Buy → Buy $2
2024-08-16 reit HC Wainwright & Co. Buy → Buy $2
2024-05-28 init Laidlaw & Co. — → Buy $3
2024-05-21 reit HC Wainwright & Co. Buy → Buy $2
2024-04-22 reit HC Wainwright & Co. Buy → Buy $2
2024-04-03 reit HC Wainwright & Co. Buy → Buy $2
2024-03-07 reit HC Wainwright & Co. Buy → Buy $2
2023-11-14 reit HC Wainwright & Co. Buy → Buy $7
2023-08-09 reit HC Wainwright & Co. — → Buy $7
2023-05-15 main HC Wainwright & Co. Buy → Buy $7
2022-11-10 main Chardan Capital — → Buy $2
2022-05-24 main Chardan Capital — → Buy $6
News
RSS: Latest PHGE news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-17 YEGANEH REUVEN Director and Beneficial Owner of more than 10% of a Class of Security — 980,000 $5.00 $4,900,000
2026-03-17 YEGANEH REUVEN Director and Beneficial Owner of more than 10% of a Class of Security — 980,000 $2.00 $1,960,000
2026-03-13 YEGANEH REUVEN Director and Beneficial Owner of more than 10% of a Class of Security — 670,000 $5.00 $3,761,000
2026-03-13 YEGANEH REUVEN Director and Beneficial Owner of more than 10% of a Class of Security — 670,000 $2.00 $1,340,000
2025-04-14 SOLOMON JONATHAN EITAN Chief Executive Officer — 126,748 $0.00 $0
2025-04-14 SOLOMON JONATHAN EITAN Chief Executive Officer — 126,748 — —
2025-04-14 BASSAN MERAV Officer — 79,597 $0.00 $0
2025-04-14 BASSAN MERAV Officer — 79,597 — —
2025-04-14 WOLFSON MARINA Chief Financial Officer — 68,545 $0.00 $0
2025-04-14 WOLFSON MARINA Chief Financial Officer — 68,545 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
35.55
+40.25%
25.35
-6.87%
27.22
-23.24%
35.46
Research And Development
24.66
+47.70%
16.70
+2.79%
16.24
-28.36%
22.68
Selling General And Administration
10.89
+25.87%
8.65
-8.52%
9.46
-16.07%
11.27
General And Administrative Expense
10.89
+25.87%
8.65
-8.52%
9.46
-16.07%
11.27
Salaries And Wages
4.35
+27.76%
3.40
-1.68%
3.46
-20.63%
4.36
Other Gand A
4.57
+35.48%
3.37
+5.31%
3.20
-22.29%
4.12
Total Expenses
35.55
+40.25%
25.35
-6.87%
27.22
-23.24%
35.46
Operating Income
-35.55
-40.25%
-25.35
+6.87%
-27.22
+23.24%
-35.46
Total Operating Income As Reported
-44.52
-75.65%
-25.35
+6.87%
-27.22
+23.24%
-35.46
EBITDA
-15.04
+34.25%
-22.87
+3.35%
-23.66
+28.07%
-32.90
Normalized EBITDA
-32.47
-40.84%
-23.05
+4.40%
-24.11
+26.52%
-32.82
Reconciled Depreciation
1.80
+107.00%
0.87
-65.44%
2.52
-1.75%
2.56
EBIT
-16.84
+29.07%
-23.74
+9.32%
-26.18
+26.16%
-35.46
Total Unusual Items
17.43
+9425.68%
0.18
-59.42%
0.45
+685.71%
-0.08
Total Unusual Items Excluding Goodwill
17.43
+9425.68%
0.18
-59.42%
0.45
+685.71%
-0.08
Special Income Charges
-8.97
0.00
—
0.00
Impairment Of Capital Assets
8.08
0.00
—
—
Restructuring And Mergern Acquisition
0.89
0.00
—
0.00
Net Income
-17.73
+32.26%
-26.17
+7.59%
-28.32
+21.83%
-36.23
Pretax Income
-17.71
+32.25%
-26.15
+7.45%
-28.25
+21.87%
-36.16
Net Non Operating Interest Income Expense
-1.74
-29.90%
-1.34
+17.31%
-1.62
-160.97%
-0.62
Interest Expense Non Operating
0.87
-63.69%
2.40
+16.19%
2.07
+195.99%
0.70
Net Interest Income
-1.74
-29.90%
-1.34
+17.31%
-1.62
-160.97%
-0.62
Interest Expense
0.87
-63.69%
2.40
+16.19%
2.07
+195.99%
0.70
Interest Income Non Operating
1.05
-6.60%
1.12
+141.81%
0.46
+439.53%
0.09
Interest Income
1.05
-6.60%
1.12
+141.81%
0.46
+439.53%
0.09
Other Income Expense
19.57
+3525.00%
0.54
-7.69%
0.58
+859.74%
-0.08
Other Non Operating Income Expenses
2.14
+500.28%
0.36
+166.42%
0.13
—
Gain On Sale Of Security
26.40
+14328.42%
0.18
-59.42%
0.45
+685.71%
-0.08
Tax Provision
0.01
-43.48%
0.02
-64.62%
0.07
-2.99%
0.07
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
0.10
+685.71%
-0.02
Net Income Including Noncontrolling Interests
-17.73
+32.26%
-26.17
+7.59%
-28.32
+21.83%
-36.23
Net Income From Continuing Operation Net Minority Interest
-17.73
+32.26%
-26.17
+7.59%
-28.32
+21.83%
-36.23
Net Income From Continuing And Discontinued Operation
-17.73
+32.26%
-26.17
+7.59%
-28.32
+21.83%
-36.23
Net Income Continuous Operations
-17.73
+32.26%
-26.17
+7.59%
-28.32
+21.83%
-36.23
Normalized Income
-35.16
-33.42%
-26.35
+8.07%
-28.66
+20.74%
-36.17
Net Income Common Stockholders
-17.73
+32.26%
-26.17
+7.59%
-28.32
+21.83%
-36.23
Diluted EPS
-27.93
+71.18%
-96.90
+46.32%
-180.50
+31.65%
-264.10
Basic EPS
-27.93
+71.18%
-96.90
+46.32%
-180.50
+31.65%
-264.10
Basic Average Shares
0.63
+134.16%
0.27
+71.94%
0.16
+14.79%
0.14
Diluted Average Shares
0.69
+155.95%
0.27
+71.94%
0.16
+14.79%
0.14
Diluted NI Availto Com Stockholders
-44.19
-68.84%
-26.17
+7.59%
-28.32
+21.83%
-36.23
Average Dilution Earnings
-26.46
0.00
—
—
Amortization
—
0.00
-100.00%
1.52
+0.00%
1.52
Amortization Of Intangibles Income Statement
—
0.00
-100.00%
1.52
+0.00%
1.52
Depreciation Amortization Depletion Income Statement
—
0.00
-100.00%
1.52
+0.00%
1.52
Depreciation And Amortization In Income Statement
—
0.00
-100.00%
1.52
+0.00%
1.52
Insurance And Claims
1.38
-12.56%
1.58
-35.55%
2.45
-1.92%
2.50
Rent And Landing Fees
0.59
+98.99%
0.30
-13.87%
0.35
+18.90%
0.29
Rent Expense Supplemental
0.59
+98.99%
0.30
-13.87%
0.35
+18.90%
0.29
Total Other Finance Cost
1.91
+3316.07%
0.06
+330.77%
0.01
+85.71%
0.01
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Assets
25.03
-45.03%
45.53
-41.62%
77.99
Current Assets
17.63
-52.19%
36.88
-44.65%
66.64
Cash Cash Equivalents And Short Term Investments
14.91
-55.28%
33.33
-46.32%
62.10
Cash And Cash Equivalents
14.91
-52.42%
31.33
-49.55%
62.10
Other Short Term Investments
0.00
-100.00%
2.00
0.00
Receivables
0.57
+1.23%
0.57
-36.15%
0.89
Other Receivables
0.57
+1.23%
0.57
-36.15%
0.89
Prepaid Assets
0.63
-57.63%
1.49
-33.54%
2.25
Restricted Cash
0.96
-0.52%
0.96
-3.41%
1.00
Other Current Assets
0.56
+6.65%
0.53
+29.24%
0.41
Total Non Current Assets
7.40
-14.49%
8.65
-23.80%
11.35
Net PPE
7.40
-14.49%
8.65
-12.03%
9.83
Gross PPE
10.88
-4.24%
11.36
-2.06%
11.60
Accumulated Depreciation
-3.48
-28.45%
-2.71
-53.45%
-1.77
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
0.68
+1.95%
0.67
-7.63%
0.72
Other Properties
7.21
-6.45%
7.71
-2.33%
7.89
Leases
2.99
+0.07%
2.99
+0.00%
2.99
Goodwill And Other Intangible Assets
0.00
0.00
-100.00%
1.52
Other Intangible Assets
—
—
1.52
Other Non Current Assets
—
—
—
Total Liabilities Net Minority Interest
21.95
-10.39%
24.49
-19.58%
30.45
Current Liabilities
11.18
+40.77%
7.94
-28.11%
11.04
Payables And Accrued Expenses
4.72
+73.20%
2.73
-66.93%
8.25
Payables
3.44
+86.64%
1.84
-69.19%
5.98
Accounts Payable
1.38
+68.41%
0.82
-70.66%
2.79
Other Payable
2.06
+101.27%
1.02
-67.90%
3.18
Current Accrued Expenses
1.29
+45.32%
0.89
-60.96%
2.27
Pensionand Other Post Retirement Benefit Plans Current
—
0.80
-72.50%
2.91
Current Debt And Capital Lease Obligation
6.45
+29.82%
4.97
+506.72%
0.82
Current Debt
5.79
+35.10%
4.28
—
Other Current Borrowings
5.79
+35.10%
4.28
—
Current Capital Lease Obligation
0.67
-3.06%
0.69
-16.12%
0.82
Current Deferred Liabilities
0.03
-88.43%
0.24
-87.75%
1.98
Current Deferred Revenue
0.03
-88.43%
0.24
-87.75%
1.98
Total Non Current Liabilities Net Minority Interest
10.77
-34.92%
16.55
-14.73%
19.41
Long Term Debt And Capital Lease Obligation
8.64
-39.95%
14.39
-25.05%
19.20
Long Term Debt
5.40
-48.99%
10.59
-26.50%
14.41
Long Term Capital Lease Obligation
3.24
-14.72%
3.80
-20.66%
4.79
Non Current Deferred Liabilities
1.98
+0.00%
1.98
0.00
Non Current Deferred Revenue
1.98
+0.00%
1.98
0.00
Other Non Current Liabilities
0.15
-17.55%
0.19
-12.56%
0.21
Stockholders Equity
3.08
-85.36%
21.04
-55.74%
47.53
Common Stock Equity
3.08
-85.36%
21.04
-55.74%
47.53
Capital Stock
0.00
+50.00%
0.00
+0.00%
0.00
Common Stock
0.00
+50.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
Share Issued
0.24
+53.36%
0.16
+0.77%
0.16
Ordinary Shares Number
0.24
+53.39%
0.16
+0.77%
0.16
Treasury Shares Number
0.00
-100.00%
0.00
+0.00%
0.00
Additional Paid In Capital
166.05
+5.20%
157.84
+1.17%
156.02
Retained Earnings
-162.97
-19.13%
-136.80
-26.10%
-108.48
Total Equity Gross Minority Interest
3.08
-85.36%
21.04
-55.74%
47.53
Total Capitalization
8.48
-73.18%
31.63
-48.94%
61.95
Working Capital
6.46
-77.69%
28.94
-47.94%
55.59
Invested Capital
14.27
-60.27%
35.91
-42.03%
61.95
Total Debt
15.09
-22.04%
19.36
-3.29%
20.02
Capital Lease Obligations
3.90
-12.93%
4.49
-20.00%
5.61
Net Tangible Assets
3.08
-85.36%
21.04
-54.28%
46.02
Tangible Book Value
3.08
-85.36%
21.04
-54.28%
46.02
Derivative Product Liabilities
0.00
—
—
Preferred Stock Equity
—
—
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-36.98
-73.72%
-21.29
+26.83%
-29.09
-5.51%
-27.57
Cash Flow From Continuing Operating Activities
-36.98
-73.72%
-21.29
+26.83%
-29.09
-5.51%
-27.57
Net Income From Continuing Operations
-17.73
+32.26%
-26.17
+7.59%
-28.32
+21.83%
-36.23
Depreciation Amortization Depletion
1.80
+107.00%
0.87
-65.44%
2.52
-1.75%
2.56
Depreciation
1.80
+107.00%
0.87
-12.99%
1.00
-4.30%
1.05
Amortization Cash Flow
—
—
1.52
+0.00%
1.52
Depreciation And Amortization
1.80
+107.00%
0.87
-65.44%
2.52
-1.75%
2.56
Amortization Of Intangibles
—
—
1.52
+0.00%
1.52
Other Non Cash Items
-2.49
-713.05%
0.41
+202.53%
-0.40
-57.14%
-0.25
Stock Based Compensation
1.85
+74.50%
1.06
-30.74%
1.53
-52.76%
3.24
Asset Impairment Charge
8.08
0.00
—
—
Operating Gains Losses
-25.50
-36022.54%
0.07
—
0.02
Gain Loss On Investment Securities
-25.73
—
—
—
Gain Loss On Sale Of PPE
0.22
+211.27%
0.07
—
0.02
Change In Working Capital
-2.99
-220.88%
2.48
+155.92%
-4.43
-242.70%
3.10
Change In Payables And Accrued Expense
-4.15
-337.20%
1.75
+133.16%
-5.28
-583.33%
1.09
Change In Payable
-4.15
-337.20%
1.75
+133.16%
-5.28
-583.33%
1.09
Change In Account Payable
-3.17
-669.60%
0.56
+128.15%
-1.98
-562.53%
0.43
Change In Other Working Capital
0.32
+439.78%
-0.09
+12.26%
-0.11
-105.36%
1.98
Change In Other Current Assets
0.84
+2.81%
0.82
-14.33%
0.96
+2796.97%
0.03
Change In Other Current Liabilities
—
—
—
0.00
Investing Cash Flow
0.71
-63.35%
1.95
+192.60%
-2.11
-113.03%
16.17
Cash Flow From Continuing Investing Activities
0.71
-63.35%
1.95
+192.60%
-2.11
-113.03%
16.17
Net PPE Purchase And Sale
0.05
+206.12%
-0.05
+54.21%
-0.11
+97.09%
-3.68
Purchase Of PPE
-0.03
+40.00%
-0.05
+55.36%
-0.11
+96.96%
-3.68
Sale Of PPE
0.08
+8100.00%
0.00
-80.00%
0.01
+25.00%
0.00
Capital Expenditure
-0.03
+40.00%
-0.05
+55.36%
-0.11
+96.96%
-3.68
Net Investment Purchase And Sale
0.00
-100.00%
2.00
+200.00%
-2.00
-110.08%
19.85
Purchase Of Investment
—
0.00
+100.00%
-13.50
0.00
Sale Of Investment
0.00
-100.00%
2.00
-82.61%
11.50
-42.07%
19.85
Net Business Purchase And Sale
0.66
0.00
—
—
Financing Cash Flow
38.37
+1223.70%
2.90
+892.81%
0.29
-99.22%
37.28
Cash Flow From Continuing Financing Activities
38.37
+1223.70%
2.90
+892.81%
0.29
-99.22%
37.28
Net Issuance Payments Of Debt
-10.75
-152.69%
-4.25
0.00
-100.00%
14.22
Issuance Of Debt
—
—
0.00
-100.00%
14.22
Repayment Of Debt
-10.75
-152.69%
-4.25
0.00
—
Long Term Debt Issuance
—
—
0.00
-100.00%
14.22
Long Term Debt Payments
-10.75
-152.69%
-4.25
0.00
—
Net Long Term Debt Issuance
-10.75
-152.69%
-4.25
0.00
-100.00%
14.22
Net Common Stock Issuance
0.02
-99.75%
7.49
+2641.76%
0.27
-98.81%
22.93
Proceeds From Stock Option Exercised
28.75
0.00
0.00
-100.00%
0.13
Net Other Financing Charges
-0.92
-175.68%
-0.33
-1852.63%
0.02
—
Changes In Cash
2.11
+112.84%
-16.44
+46.82%
-30.91
-219.42%
25.88
Effect Of Exchange Rate Changes
0.00
-83.33%
0.01
-94.34%
0.11
+524.00%
-0.03
Beginning Cash Position
15.86
-50.88%
32.29
-48.82%
63.09
+69.43%
37.24
End Cash Position
17.98
+13.31%
15.86
-50.88%
32.29
-48.82%
63.09
Free Cash Flow
-37.01
-73.46%
-21.34
+26.94%
-29.20
+6.56%
-31.25
Interest Paid Supplemental Data
1.44
-23.01%
1.87
+20.53%
1.55
+2219.40%
0.07
Income Tax Paid Supplemental Data
0.01
-75.93%
0.05
-16.92%
0.07
-83.71%
0.40
Common Stock Issuance
0.02
-99.75%
7.49
+2641.76%
0.27
-98.81%
22.93
Issuance Of Capital Stock
21.29
+184.41%
7.49
+2641.76%
0.27
-98.81%
22.93
Net Preferred Stock Issuance
21.27
0.00
—
—
Preferred Stock Issuance
21.27
0.00
—
—
Sale Of Business
0.66
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category